C-peptide: much more than a byproduct of insulin biosynthesis.
about
Increased Insulin following an Oral Glucose Load, Genetic Variation near the Melatonin Receptor MTNR1B, but No Biochemical Evidence of Endothelial Dysfunction in Young Asian Men and WomenMaterials for diabetes therapeutics.C-peptide microheterogeneity in type 2 diabetes populations.Significance of plasma C-peptide in obese African American adolescents.Overexpression of Insulin Degrading Enzyme could Greatly Contribute to Insulin Down-regulation Induced by Short-Term Swimming Exercise.Centrally mediated erectile dysfunction in rats with type 1 diabetes: role of angiotensin II and superoxide.Effects of Vitamin D Supplementation on C-peptide and 25-hydroxyvitamin D Concentrations at 3 and 6 Months.Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality.Lack of associations between betatrophin/ANGPTL8 level and C-peptide in type 2 diabetic subjects.Future detection and monitoring of diabetes may entail analysis of both β-cell function and volume: how markers of β-cell loss may assist.History and diagnostic significance of C-peptide.Enhanced differentiation of human amniotic fluid-derived stem cells into insulin-producing cells in vitro.Insulin in the brain: sources, localization and functions.Pathological consequences of C-peptide deficiency in insulin-dependent diabetes mellitus.The diagnosis of equine insulin dysregulation.Conditions of gestation, childbirth and childhood associated with C-peptide in young adults in the 1982 Birth Cohort in Pelotas-RS; Brazil.In vitro and in vivo effect of acylated and unacylated ghrelin on neonatal glucose homeostasis.Evaluation of commercial ELISA and RIA for measuring porcine C-peptide: implications for research.The effect of oral and intravenous dextrose on C-peptide secretion in ponies.Regular consumption of pulses for 8 weeks reduces metabolic syndrome risk factors in overweight and obese adults.Increased Circulation and Adipose Tissue Levels of DNAJC27/RBJ in Obesity and Type 2-Diabetes
P2860
Q28546709-E2F3083F-4F94-4C82-8FF8-8D5C0A5B54C9Q30444149-DF955E3F-4366-4C92-9BEE-D8B2AC8488BAQ33764455-41DFF790-E6AD-40EF-AB7F-1933F609315EQ33821245-F39608D8-D62B-49C8-A671-A5CEB5675585Q35134881-2A104887-3041-4AEB-A751-7290ABF1A549Q35733922-B112EC65-34DF-4372-A844-61D63EA77CE1Q35764892-C44C30C9-C0D9-4588-9082-6C6485A3E1B3Q35817986-CFBFA6DC-3229-42AA-B9B7-3253C6A8C846Q35986455-8AFC7A8F-C0B6-458F-9EAC-7807B0843F79Q36402230-91F324FC-FA79-45C1-B0CD-88B168A694C1Q37176063-C191598A-7465-42CA-BF51-0A956D79D2B3Q37567673-017D29A0-74CD-4705-AEA6-78038ACFC3B8Q38041488-F113732C-5D7D-45BE-B971-EA4AF1B8AB0FQ38356851-56E87661-B1EB-4AE8-BA24-AE15A0C2F052Q39329444-A7C53C42-E903-4F06-ABEB-D5C79D1D2329Q40485115-63A4935B-3262-4F60-AC98-737CC81719DDQ43055879-7E41CEFC-FD4E-42CD-8532-C92E458667C7Q45341153-ADCCE847-02C1-4772-939A-E1BC99D7E5A0Q46565923-C1AC1358-D749-4730-BB39-84D56299DECBQ51352411-06779BA0-08E4-4F61-9BF7-D3404ED90037Q58797174-8B832666-15A3-46AC-B58C-024A744D9A13
P2860
C-peptide: much more than a byproduct of insulin biosynthesis.
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
C-peptide: much more than a byproduct of insulin biosynthesis.
@ast
C-peptide: much more than a byproduct of insulin biosynthesis.
@en
type
label
C-peptide: much more than a byproduct of insulin biosynthesis.
@ast
C-peptide: much more than a byproduct of insulin biosynthesis.
@en
prefLabel
C-peptide: much more than a byproduct of insulin biosynthesis.
@ast
C-peptide: much more than a byproduct of insulin biosynthesis.
@en
P2093
P1433
P1476
C-peptide: much more than a byproduct of insulin biosynthesis.
@en
P2093
Jeffrey Rogers
Magali J Fontaine
Ruy G Marques
P304
P356
10.1097/00006676-200410000-00009
P577
2004-10-01T00:00:00Z